Canada markets closed

Oncolytics Biotech Inc (ONYN.MU)

Munich - Munich Delayed Price. Currency in EUR
Add to watchlist
1.28000.0000 (0.00%)
At close: 02:31PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
19,913
17,709
15,432
12,920
12,945
Selling General and Administrative
15,467
15,679
11,100
12,863
12,514
Total Operating Expenses
35,783
33,791
26,924
26,235
25,459
Operating Income or Loss
-35,783
-33,791
-26,924
-26,235
-25,459
Total Other Income/Expenses Net
6,164
4,810
1,645
-119
2,833
Income Before Tax
-28,112
-27,655
-24,751
-26,255
-22,505
Income Tax Expense
-
97
84
49
0
Income from Continuing Operations
-28,209
-27,752
-24,835
-26,304
-22,505
Net Income
-28,209
-27,752
-24,835
-26,304
-22,505
Net Income available to common shareholders
-28,209
-27,752
-24,835
-26,304
-22,505
Basic EPS
-0.51
-0.41
-0.43
-0.49
-0.56
Diluted EPS
-0.51
-0.41
-0.43
-0.49
-0.56
Basic Average Shares
64,057
67,624
58,030
53,513
40,339
Diluted Average Shares
64,057
67,624
58,030
53,513
40,339